Cogstate Scientific Presentations at CTAD
For 20 years, Cogstate has proudly supported the leading-edge research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and patients around the world, with particular emphasis and experience in Alzheimer’s Disease. We are pleased to be part of the CTAD program.
- Symposium | Nov 30 @ 1:20 PM: Decentralization Approaches for Clinical Trials on Alzheimer’s Disease | Presentation 2: Effects of supervision on cognitive and functional assessment outcomes (Paul Maruff, Presenter)
- Oral Communication | Dec 2 @ 2:05 PM: Preliminary evidence for reliability and validity of the Interpersonal Functioning and Daily Activities Questionnaire (IFDAQ) in the A4/LEARN pre-randomization sample (Chris Edgar, Presenter)
- Poster: XanaMIA Phase 1b trial with Xanamem® achieves primary endpoints: results and strategic update (Paul Maruff, Co-Author)
- Poster: Clinical Activity of the p38⍺ kinase inhibitor neflamapimod on verbal list learning may be tau pathology dependent in dementia with Lewy bodies (DLB) (Cogstate assessments utilized)
Cogstate Experts Involved in Presentations